Elekta, SE0000163628

Why Elekta Harmony wants to make radiotherapy feel less intimidating

20.06.2026 - 03:16:44 | ad-hoc-news.de

Elekta Harmony is not the company’s flashiest machine, but its compact design and smoother workflows aim to make everyday radiotherapy more tolerable for patients and more efficient for clinics. A closer look at what this mid-range linac really delivers.

Elekta, SE0000163628
Elekta, SE0000163628

Reviewed: ad hoc news B2B & Pro desk. Edited and checked on 2026-06-20, 03:15. Details in the imprint.

With Elekta Harmony, the treatment room looks a little less like a science-fiction lab and a bit more like a calm, tidy workspace where a patient might actually breathe out. The gantry is compact, the couch moves quietly, and the ceiling can stay surprisingly uncluttered.

Go deeper

Background on the Elekta AB stock

Elekta Harmony sits at the heart of the Swedish company’s radiotherapy line-up - investors follow it as a workhorse system that can shift both market share and recurring service revenue.

What Elekta Harmony aims to change

Harmony is Elekta’s mid-range linear accelerator that tries to balance advanced beam shaping with a smaller room footprint and simpler workflows for staff. Its design focuses on everyday treatments like breast, prostate, and head-and-neck cancer rather than ultra-exotic use cases.

The machine is built around a gantry that feels less bulky than older linacs. That matters because many cancer centers operate in cramped, retrofit bunkers where every centimeter of clearance, cable routing, and shielding is a negotiation with the architect.

Compact room, quieter workflow

From a patient’s perspective, the first impression is the shorter distance between the machine and the walls. The couch rolls into position, the headrest clicks into place, and the large circular gantry arcs overhead without towering like an industrial robot.

Therapists benefit from a cleaner floor and ceiling, with fewer dangling accessories and less need to squeeze around the gantry. Shorter couch travel and a smaller isocenter clearance can shave seconds here and there, which adds up over dozens of fractions per day.

Imaging and beam delivery in practice

Elekta positions Harmony as a system with modern multi-leaf collimator technology and integrated imaging for daily setup, but without the full-on MRI integration of Elekta Unity. That keeps complexity, room requirements, and acquisition cost at a more practical level for many hospitals.

Typical image-guided radiotherapy workflows run with cone-beam CT or 2D kV imaging before each session. Patients will mostly notice a brief scan, a few couch adjustments, and then the fast rotation of the gantry as treatment beams are delivered.

Strengths for busy cancer centers

Hospitals that struggle with long waiting lists care less about headline specs and more about how many patients can realistically pass through in one day. Harmony’s compact footprint and streamlined start-up sequences target exactly this bottleneck.

The system also dovetails with Elekta’s software ecosystem for planning and record-and-verify. That tight integration is not glamorous, but it reduces double data entry, cuts down on manual checks, and can lower the risk of treatment interruptions.

Where compromise shows up

Because Harmony is not Elekta’s flagship, it does not offer the MRI-guided adaptive radiotherapy that Unity brings to the table, nor does it chase the absolute highest dose rates on the market. Centers that want those features will look further up the range.

For some indications, particularly those that benefit from daily soft-tissue visualization, this means clinicians still have to work with anatomical surrogates on x-ray or CT. That is proven and robust, but less ambitious than cutting-edge image guidance.

Pricing, positioning, and Elekta’s share

In Europe and many emerging markets, Harmony is pitched as a workhorse linac that should be easier to justify in capital budgets than a full premium system. It is meant to replace aging accelerators and to expand capacity where there has never been radiotherapy before.

Bottom line, Elekta AB sees systems like Harmony as central to its installed base and long-term service revenue, with the company’s shares (SE0000163628) primarily trading on Nasdaq Stockholm as a reference point for investors watching adoption.

Key facts on Elekta Harmony

  • Product: Elekta Harmony
  • Manufacturer: Elekta AB
  • Category: B2B/Pro line radiotherapy system
  • Launch: Around mid-2020s as a compact linac platform
  • RRP / Price: Not officially disclosed, typically several million in local currency per system
  • Availability: Selected cancer centers worldwide via Elekta sales partners and direct tenders
  • Target group: Hospitals and radiotherapy centers seeking a modern, mid-range linear accelerator
  • Highlight / USP: Compact treatment room requirements combined with contemporary imaging and beam delivery for everyday indications

More impressions and opinions

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | SE0000163628 | ELEKTA | boerse | 69586816 | bgmi